Oregon Public Employees Retirement Fund Allogene Therapeutics, Inc. Transaction History

Oregon Public Employees Retirement Fund

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$6.78 - $12.28 $267,511 - $484,519	-39,456 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$25.24 - $43.45 $126,199 - $217,250	-5,000 Reduced 11.25%	39,456 $996,000
Q3 2020 Nov 03, 2020	BUY	$32.38 - $44.96 $1.44 Million - $2 Million	44,456 New	44,456 $1.68 Million

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.